title: Sharp drop in the prevalence of human cytomegalovirus leuko-DNAemia in HIV-infected patients following highly active antiretroviral therapy.
authors.forename: G
authors.initials: G
authors.lastname: Gerna
authors.forename: A
authors.initials: A
authors.lastname: d'Arminio Monforte
authors.forename: M
authors.initials: M
authors.lastname: Zavattoni
authors.forename: A
authors.initials: A
authors.lastname: Sarasini
authors.forename: L
authors.initials: L
authors.lastname: Testa
authors.forename: M G
authors.initials: MG
authors.lastname: Revello
authors.forename: M
authors.initials: M
authors.lastname: Moroni
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000453:epidemiology* / Q000821:virology*; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D003587:Cytomegalovirus / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000453:epidemiology*; D004279:DNA, Viral / Q000097:blood / Q000302:isolation & purification; D006678:HIV / Q000302:isolation & purification; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000821:virology; D016133:Polymerase Chain Reaction; D015995:Prevalence; D012367:RNA, Viral / Q000097:blood / Q000302:isolation & purification
chemical_list: D019380:Anti-HIV Agents; D004279:DNA, Viral; D012367:RNA, Viral